Physician profile
Paul Suarez
NPI 1649245861
$2,983.88
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,045 · 2021: $333 · 2023: $1,606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,033 · Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,032.88 |
| Food and Beverage | $572.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,547.51 | 2023 | Journey II, Real Intelligence, Legion Revision |
| Wright Medical Technology, INC. | $1,045.06 | 2019 | |
| Zimmer Biomet Holdings, INC. | $333.30 | 2021 | |
| Stryker Corporation | $36.68 | 2023 | T2 Alpha |
| Sioux Surgical INC | $21.33 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Suarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.